OxSyBio Overview
- Year Founded
-
2014

- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
OxSyBio General Information
Description
Developer of 3D printing techniques designed to produce a range of tissue-like and functional tissues for medical research and clinical applications. The company's 3D printing techniques include developing a method of printing tissue-like materials comprised of 3-dimensional networks of lipid monolayer aqueous droplets, that are capable of conducting electrical signals along pre-defined pathways and self-folding to form complex geometries, enabling users to access a range of applications in regenerative medicine and synthetic biology.
Contact Information
- The Walbrook Building
- 25 Walbrook
- London EC4N 8AF
- England, United Kingdom
OxSyBio Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Out of Business | 01-Oct-2019 | 000.00 | Completed | Out of Business | ||
2. Early Stage VC | 16-Jul-2018 | 000.00 | 000.00 | 000.00 | Completed | Generating Revenue |
1. Early Stage VC | 11-Nov-2015 | $1.54M | $1.54M | 00.000 | Completed | Generating Revenue |
OxSyBio Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Ordinary | 0,000 | 00.000000 | 0000.00 | 0000.00 | 00 | 0000.00 | 0.000 | |
Preference | 0,000 | 00.000000 | 0000.00 | 0000.00 | 00 | 0000.00 | 00.000 | |
A Ordinary | 3,134 | $0.002643 | $210.83 | $210.83 | 1x | $210.83 | 11.05% | |
Ordinary | 5,240 | $0.013215 | $132.15 | $132.15 | 1x | $132.15 | 18.47% |
OxSyBio Comparisons
Industry
Financing
Details
OxSyBio Competitors (1)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
00000000 | Formerly VC-backed | San Diego, CA | 00 | 000.00 | 000000&0 |